Breaking Bad News in Cancer Care: Ethiopian Patients Want More Information Than What Family and the Public Want Them to Have.
Journal
JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
entrez:
7
9
2021
pubmed:
8
9
2021
medline:
3
11
2021
Statut:
ppublish
Résumé
This study explores the preferences of patients with cancer, family caregivers, and the general public regarding breaking bad news in an Ethiopian oncology setting. The study was conducted at Tikur Anbessa (Black Lion) Specialized Hospital. The sample consists of patients with a confirmed cancer diagnosis, their family caregivers, and representatives from the general public with 150 subjects per cohort. The study used a comparative cross-sectional design and multivariable data analysis. The patients would like to be informed, which contradicts the preferences of family caregivers. This creates an ethical dilemma for staff in terms of how much they involve their patients in clinical decision making. The patients also indicate that information should not be withheld from them. By contrast, the general public prefers information about poor life expectancy to be communicated to family only, which may reflect a widespread public perception of cancer as a deadly disease. The findings indicate the complexity of communication-related preferences concerning breaking bad news in oncology care in Ethiopia. It requires oncologists to probe patient attitudes before information disclosure to find a balance between involving patients in communication at the same time as keeping a constructive alliance with family caregivers.
Identifiants
pubmed: 34491813
doi: 10.1200/GO.21.00190
pmc: PMC8423395
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1341-1348Références
Palliat Med. 1996 Jul;10(3):195-200
pubmed: 8817589
Curr Oncol. 2015 Aug;22(4):e264-72
pubmed: 26300677
Asian Bioeth Rev. 2020 Mar 5;12(1):27-36
pubmed: 33717329
Nurse Pract. 2012 Feb 12;37(2):1-4
pubmed: 22252021
BMC Cancer. 2013 Feb 08;13:69
pubmed: 23391288
J Palliat Med. 2018 May;21(5):622-630
pubmed: 29425055
J Glob Oncol. 2016 Apr 20;2(5):268-274
pubmed: 28717713
Indian J Palliat Care. 2009 Jan;15(1):2-9
pubmed: 20606848
BJU Int. 2004 Jan;93(1):47-51
pubmed: 14678366
Ann N Y Acad Sci. 1997 Feb 20;809:290-9
pubmed: 9103580
BMC Public Health. 2018 Aug 29;18(1):1072
pubmed: 30157813
Support Care Cancer. 2013 Apr;21(4):1089-95
pubmed: 23108473
J Glob Health. 2019 Jun;8(2):020301
pubmed: 30774938
CA Cancer J Clin. 2005 May-Jun;55(3):164-77
pubmed: 15890639
Asian Pac J Cancer Prev. 2016;17(4):1779-84
pubmed: 27221852
Support Care Cancer. 2004 Mar;12(3):147-54
pubmed: 15074312
PLoS One. 2020 Mar 13;15(3):e0230309
pubmed: 32168353
Ethiop J Health Sci. 2017 May;27(3):255-262
pubmed: 29217924
J Cancer Prev. 2019 Sep;24(3):163-172
pubmed: 31624722
Int J Equity Health. 2012 Dec 29;11:83
pubmed: 23273140
J Cancer Prev. 2019 Mar;24(1):33-42
pubmed: 30993093
J Clin Oncol. 1998 May;16(5):1961-8
pubmed: 9586916
Glob Public Health. 2011;6(7):719-31
pubmed: 20865612
Palliat Support Care. 2013 Feb;11(1):69-78
pubmed: 23171758
West J Med. 1992 Sep;157(3):328-32
pubmed: 1413779